ABx Group Limited Raises AU$6.05 Million to Advance Rare Earths and ALCORE Pilot Plant
ABx Group Limited (ASX: ABX) has secured firm commitments to raise approximately AU$6.05 million through a placement to sophisticated and professional investors, with strong participation from new Australian and international institutions. The issue price of AU$0.081 per share reflects a material discount to recent trading levels, and participants will receive one attaching option for every two new shares, exercisable at AU$0.10 and expiring in November 2027, subject to shareholder approval.
Proceeds will accelerate the advancement of the Deep Leads rare earths project in Tasmania—Australia’s highest-ranking ionic absorption clay deposit for dysprosium and terbium—and fund construction and commissioning of the ALCORE pilot plant, designed to convert aluminium smelter by-product into hydrogen fluoride. Additional funds will support drilling across new tenements, resource expansion, engineering and metallurgical studies, and securing future offtake. Management and Board commitments of AU$100,000 underscore confidence in ABX’s growth trajectory as it progresses toward partnerships and near-term production.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
ABx Group Limited Raises AU$6.05 Million to Advance Rare Earths and ALCORE Pilot Plant
ABx Group Limited (ASX: ABX) has secured firm commitments to raise approximately AU$6.05 million through a placement to sophisticated and professional investors, with strong participation from new Australian and international institutions. The issue price of AU$0.081 per share reflects a material discount to recent trading levels, and participants will receive one attaching option for every two new shares, exercisable at AU$0.10 and expiring in November 2027, subject to shareholder approval.
Proceeds will accelerate the advancement of the Deep Leads rare earths project in Tasmania—Australia’s highest-ranking ionic absorption clay deposit for dysprosium and terbium—and fund construction and commissioning of the ALCORE pilot plant, designed to convert aluminium smelter by-product into hydrogen fluoride. Additional funds will support drilling across new tenements, resource expansion, engineering and metallurgical studies, and securing future offtake. Management and Board commitments of AU$100,000 underscore confidence in ABX’s growth trajectory as it progresses toward partnerships and near-term production.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au.au